Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes.

Source:http://linkedlifedata.com/resource/pubmed/id/19929995

Download in:

View as

General Info

PMID
19929995